The exploratory endpoints included correlation of persistence, phenotype and functionality of transduced (afami-cel) and non-transduced T cells in the peripheral blood and/or tumor in response to treatment and safety; determination of target antigen expression, genes related to antigen processing/presentation and cell surface co-stimulatory ligands; and evaluation of serum cytokines (IL-6). The gene discussed is IL6; the disease is neoplasm.